Loading...
Please wait, while we are loading the content...
Molecular remission of Philadelphia/bcr-abl-positive acute myeloid leukaemia after treatment with anti-CD33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676)
| Content Provider | Scilit |
|---|---|
| Author | Vetten, M. P. De Jansen, J. H. Reijden, B. A. Van Der Berger, M. S. Zijlmans, J. M. J. M. Löwenberg, B. |
| Copyright Year | 2000 |
| Description | Journal: British Journal of Haematology |
| Ending Page | 279 |
| Starting Page | 277 |
| ISSN | 2573508X |
| e-ISSN | 13652141 |
| DOI | 10.1111/j.1365-2141.2000.02402.x |
| Journal | British Journal of Haematology |
| Issue Number | 1 |
| Volume Number | 111 |
| Language | English |
| Publisher | Wiley-Blackwell |
| Publisher Date | 2000-10-01 |
| Access Restriction | Open |
| Subject Keyword | Journal: British Journal of Haematology Acute Myeloid Leukaemia Gemtuzumab Ozogamicin (cma‐676) |
| Content Type | Text |
| Resource Type | Article |